Compare Abeona Therapeutics Inc (ABEO) vs Amplitude Inc (AMPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Amplitude Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Amplitude Inc trades at $12.78 (market cap $1.59B). The key difference: Amplitude Inc is far larger — about 3.8× Abeona Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| ABEO | AMPL | |
|---|---|---|
Market Cap | $421.19M | $1.59B |
Sector | Health | Technology |
52-Week High | $7.45 | $12.69 |
52-Week Low | $4.17 | $5.61 |
Enterprise Value | $276.10M | $1.45B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Amplitude Inc
Amplitude Inc is pioneering a new category of software called digital optimization. The company's digital optimization system serves as the command center for businesses to connect digital products to business outcomes.
Read more on AMPL →
